Published on July 11th, 2017 | by Wieslab0
Experts in bioanalysis for Pharmacokinetic testing of large molecules
The importance of Pharmacokinetic testing
When designing the dose, route, and schedule of administration of a drug to maximize effectiveness it is important to reduce adverse effects. To understand the behavior of a drug requires Pharmacokinetic testing.
Consulting in Pharmacokinetic testing
Wieslab is an expert in bioanalysis for Pharmacokinetic testing of large molecules. We therefore consult with clients and experts in Pharmakokinetics and Pharmacodynamics on appropriate analytical approach for pre-clinical and clinical studies.
Ligand Binding Assays (LBA), used for bioanalytical methods, are utilized to determine drug concentration in biological fluids. Our scientists use ELISA, RIA or Electrochemiluminescence (ECL)-based assays to perform pharmacokinetic testing.
High quality standards and processes are essential when working in bioanalytical projects. The scientists that manage and staff our GCP, GLP, and ISO 17025 compliant laboratory all have significant experience in regulated environments. Moreover, our scientists have long experience meeting guidelines from the EMA and the FDA.
Our scientists attend international workshops and forums such as the European Bioanalytical Forum to stay up to date on the latest developments. We´re ready to help our clients in the best possible way to accelerate their discovery and development programs.
Contact us today to discuss the design of the perfect assay for your drug!